The antiviral pill Paxlovid does not significantly reduce COVID-19 hospitalizations in vaccinated older adults, according to new research by UCLA doctors. The findings, published Thursday in a research letter in the Journal of the American Medical Association (JAMA),

Paxlovid may not decrease the risk for hospitalization or death in older adults vaccinated against COVID-19 as much as previously thought, according to research published in JAMA.

React 19 co-chair Brianne Dressen discusses a study investigating the post-vaccination issues linked to the coronavirus vaccine.

In today’s health headlines, we’re talking about fluoride being removed from drinking water in one state, the “died suddenly” claims during COVID, and a new study examining the cause of “post-vaccine syndrome.